nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.27	0.343	CbGbCtD
Thiabendazole—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.232	0.295	CbGbCtD
Thiabendazole—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.13	0.165	CbGbCtD
Thiabendazole—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.104	0.132	CbGbCtD
Thiabendazole—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0508	0.0645	CbGbCtD
Thiabendazole—Lansoprazole—ABCB1—peripheral nervous system neoplasm	0.0011	1	CrCbGaD
Thiabendazole—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.000788	0.00373	CcSEcCtD
Thiabendazole—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000785	0.00371	CcSEcCtD
Thiabendazole—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.000782	0.0037	CcSEcCtD
Thiabendazole—Anorexia—Topotecan—peripheral nervous system neoplasm	0.000762	0.0036	CcSEcCtD
Thiabendazole—Chills—Alitretinoin—peripheral nervous system neoplasm	0.000759	0.00359	CcSEcCtD
Thiabendazole—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.000756	0.00357	CcSEcCtD
Thiabendazole—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.000756	0.00357	CcSEcCtD
Thiabendazole—Coordination abnormal—Epirubicin—peripheral nervous system neoplasm	0.00075	0.00355	CcSEcCtD
Thiabendazole—Anorexia—Melphalan—peripheral nervous system neoplasm	0.000746	0.00353	CcSEcCtD
Thiabendazole—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000741	0.0035	CcSEcCtD
Thiabendazole—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000741	0.0035	CcSEcCtD
Thiabendazole—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.000737	0.00348	CcSEcCtD
Thiabendazole—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000731	0.00346	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Etoposide—peripheral nervous system neoplasm	0.000729	0.00345	CcSEcCtD
Thiabendazole—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000717	0.00339	CcSEcCtD
Thiabendazole—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000711	0.00336	CcSEcCtD
Thiabendazole—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000705	0.00333	CcSEcCtD
Thiabendazole—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000705	0.00333	CcSEcCtD
Thiabendazole—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.000703	0.00333	CcSEcCtD
Thiabendazole—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.000698	0.0033	CcSEcCtD
Thiabendazole—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.000698	0.0033	CcSEcCtD
Thiabendazole—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000695	0.00328	CcSEcCtD
Thiabendazole—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000694	0.00328	CcSEcCtD
Thiabendazole—Coordination abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000694	0.00328	CcSEcCtD
Thiabendazole—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000694	0.00328	CcSEcCtD
Thiabendazole—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000689	0.00326	CcSEcCtD
Thiabendazole—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000689	0.00326	CcSEcCtD
Thiabendazole—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000689	0.00326	CcSEcCtD
Thiabendazole—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000689	0.00326	CcSEcCtD
Thiabendazole—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000683	0.00323	CcSEcCtD
Thiabendazole—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000683	0.00323	CcSEcCtD
Thiabendazole—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000682	0.00322	CcSEcCtD
Thiabendazole—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00068	0.00322	CcSEcCtD
Thiabendazole—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000674	0.00319	CcSEcCtD
Thiabendazole—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000672	0.00318	CcSEcCtD
Thiabendazole—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000669	0.00316	CcSEcCtD
Thiabendazole—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000658	0.00311	CcSEcCtD
Thiabendazole—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000657	0.00311	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000653	0.00309	CcSEcCtD
Thiabendazole—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000653	0.00309	CcSEcCtD
Thiabendazole—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000653	0.00309	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000648	0.00306	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000648	0.00306	CcSEcCtD
Thiabendazole—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000638	0.00302	CcSEcCtD
Thiabendazole—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.000635	0.003	CcSEcCtD
Thiabendazole—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000632	0.00299	CcSEcCtD
Thiabendazole—Lymphadenopathy—Epirubicin—peripheral nervous system neoplasm	0.000627	0.00296	CcSEcCtD
Thiabendazole—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000627	0.00296	CcSEcCtD
Thiabendazole—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000627	0.00296	CcSEcCtD
Thiabendazole—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000624	0.00295	CcSEcCtD
Thiabendazole—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000618	0.00292	CcSEcCtD
Thiabendazole—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000614	0.00291	CcSEcCtD
Thiabendazole—Flushing—Etoposide—peripheral nervous system neoplasm	0.000612	0.0029	CcSEcCtD
Thiabendazole—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000606	0.00286	CcSEcCtD
Thiabendazole—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000601	0.00284	CcSEcCtD
Thiabendazole—Hepatic failure—Epirubicin—peripheral nervous system neoplasm	0.000595	0.00281	CcSEcCtD
Thiabendazole—Chills—Etoposide—peripheral nervous system neoplasm	0.000592	0.0028	CcSEcCtD
Thiabendazole—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000591	0.00279	CcSEcCtD
Thiabendazole—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000589	0.00278	CcSEcCtD
Thiabendazole—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000584	0.00276	CcSEcCtD
Thiabendazole—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000584	0.00276	CcSEcCtD
Thiabendazole—Lymphadenopathy—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.00274	CcSEcCtD
Thiabendazole—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000579	0.00274	CcSEcCtD
Thiabendazole—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000576	0.00273	CcSEcCtD
Thiabendazole—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000573	0.00271	CcSEcCtD
Thiabendazole—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000573	0.00271	CcSEcCtD
Thiabendazole—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000569	0.00269	CcSEcCtD
Thiabendazole—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000569	0.00269	CcSEcCtD
Thiabendazole—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000565	0.00267	CcSEcCtD
Thiabendazole—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000563	0.00266	CcSEcCtD
Thiabendazole—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000561	0.00265	CcSEcCtD
Thiabendazole—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000561	0.00265	CcSEcCtD
Thiabendazole—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.00265	CcSEcCtD
Thiabendazole—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000561	0.00265	CcSEcCtD
Thiabendazole—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000561	0.00265	CcSEcCtD
Thiabendazole—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000559	0.00264	CcSEcCtD
Thiabendazole—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000553	0.00262	CcSEcCtD
Thiabendazole—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000552	0.00261	CcSEcCtD
Thiabendazole—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000551	0.0026	CcSEcCtD
Thiabendazole—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000547	0.00259	CcSEcCtD
Thiabendazole—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000543	0.00257	CcSEcCtD
Thiabendazole—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000542	0.00256	CcSEcCtD
Thiabendazole—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000542	0.00256	CcSEcCtD
Thiabendazole—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000541	0.00256	CcSEcCtD
Thiabendazole—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000535	0.00253	CcSEcCtD
Thiabendazole—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000534	0.00253	CcSEcCtD
Thiabendazole—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000534	0.00252	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00053	0.00251	CcSEcCtD
Thiabendazole—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000529	0.0025	CcSEcCtD
Thiabendazole—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000528	0.0025	CcSEcCtD
Thiabendazole—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000524	0.00248	CcSEcCtD
Thiabendazole—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000524	0.00248	CcSEcCtD
Thiabendazole—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000522	0.00247	CcSEcCtD
Thiabendazole—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000518	0.00245	CcSEcCtD
Thiabendazole—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000514	0.00243	CcSEcCtD
Thiabendazole—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000512	0.00242	CcSEcCtD
Thiabendazole—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000512	0.00242	CcSEcCtD
Thiabendazole—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000508	0.0024	CcSEcCtD
Thiabendazole—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000504	0.00238	CcSEcCtD
Thiabendazole—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000504	0.00238	CcSEcCtD
Thiabendazole—Rash—Topotecan—peripheral nervous system neoplasm	0.000504	0.00238	CcSEcCtD
Thiabendazole—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000503	0.00238	CcSEcCtD
Thiabendazole—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000503	0.00238	CcSEcCtD
Thiabendazole—Headache—Topotecan—peripheral nervous system neoplasm	0.000501	0.00237	CcSEcCtD
Thiabendazole—Rash—Tretinoin—peripheral nervous system neoplasm	0.0005	0.00236	CcSEcCtD
Thiabendazole—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0005	0.00236	CcSEcCtD
Thiabendazole—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000499	0.00236	CcSEcCtD
Thiabendazole—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000499	0.00236	CcSEcCtD
Thiabendazole—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000499	0.00236	CcSEcCtD
Thiabendazole—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000498	0.00235	CcSEcCtD
Thiabendazole—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000497	0.00235	CcSEcCtD
Thiabendazole—Headache—Tretinoin—peripheral nervous system neoplasm	0.000497	0.00235	CcSEcCtD
Thiabendazole—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000497	0.00235	CcSEcCtD
Thiabendazole—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000495	0.00234	CcSEcCtD
Thiabendazole—Rash—Melphalan—peripheral nervous system neoplasm	0.000493	0.00233	CcSEcCtD
Thiabendazole—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000493	0.00233	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000491	0.00232	CcSEcCtD
Thiabendazole—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000488	0.00231	CcSEcCtD
Thiabendazole—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000478	0.00226	CcSEcCtD
Thiabendazole—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000477	0.00226	CcSEcCtD
Thiabendazole—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000475	0.00225	CcSEcCtD
Thiabendazole—Nausea—Topotecan—peripheral nervous system neoplasm	0.000475	0.00224	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000473	0.00224	CcSEcCtD
Thiabendazole—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000473	0.00224	CcSEcCtD
Thiabendazole—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000471	0.00223	CcSEcCtD
Thiabendazole—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000471	0.00223	CcSEcCtD
Thiabendazole—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000469	0.00222	CcSEcCtD
Thiabendazole—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000465	0.0022	CcSEcCtD
Thiabendazole—Nausea—Melphalan—peripheral nervous system neoplasm	0.000465	0.0022	CcSEcCtD
Thiabendazole—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000458	0.00216	CcSEcCtD
Thiabendazole—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000447	0.00211	CcSEcCtD
Thiabendazole—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000445	0.0021	CcSEcCtD
Thiabendazole—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000443	0.0021	CcSEcCtD
Thiabendazole—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.00209	CcSEcCtD
Thiabendazole—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000438	0.00207	CcSEcCtD
Thiabendazole—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000431	0.00204	CcSEcCtD
Thiabendazole—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000426	0.00202	CcSEcCtD
Thiabendazole—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00201	CcSEcCtD
Thiabendazole—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000422	0.00199	CcSEcCtD
Thiabendazole—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00197	CcSEcCtD
Thiabendazole—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000417	0.00197	CcSEcCtD
Thiabendazole—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000415	0.00196	CcSEcCtD
Thiabendazole—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000412	0.00195	CcSEcCtD
Thiabendazole—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000412	0.00195	CcSEcCtD
Thiabendazole—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.00194	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000409	0.00193	CcSEcCtD
Thiabendazole—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000408	0.00193	CcSEcCtD
Thiabendazole—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000408	0.00193	CcSEcCtD
Thiabendazole—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000404	0.00191	CcSEcCtD
Thiabendazole—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000402	0.0019	CcSEcCtD
Thiabendazole—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.00188	CcSEcCtD
Thiabendazole—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000396	0.00187	CcSEcCtD
Thiabendazole—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000393	0.00186	CcSEcCtD
Thiabendazole—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000386	0.00183	CcSEcCtD
Thiabendazole—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.00182	CcSEcCtD
Thiabendazole—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000385	0.00182	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000383	0.00181	CcSEcCtD
Thiabendazole—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000383	0.00181	CcSEcCtD
Thiabendazole—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000382	0.00181	CcSEcCtD
Thiabendazole—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.0018	CcSEcCtD
Thiabendazole—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.00179	CcSEcCtD
Thiabendazole—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000378	0.00179	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000378	0.00179	CcSEcCtD
Thiabendazole—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000377	0.00178	CcSEcCtD
Thiabendazole—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000376	0.00178	CcSEcCtD
Thiabendazole—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.00176	CcSEcCtD
Thiabendazole—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000371	0.00175	CcSEcCtD
Thiabendazole—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00174	CcSEcCtD
Thiabendazole—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000368	0.00174	CcSEcCtD
Thiabendazole—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000367	0.00174	CcSEcCtD
Thiabendazole—Rash—Vincristine—peripheral nervous system neoplasm	0.000365	0.00173	CcSEcCtD
Thiabendazole—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000365	0.00172	CcSEcCtD
Thiabendazole—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.00172	CcSEcCtD
Thiabendazole—Headache—Vincristine—peripheral nervous system neoplasm	0.000363	0.00171	CcSEcCtD
Thiabendazole—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000357	0.00169	CcSEcCtD
Thiabendazole—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000357	0.00169	CcSEcCtD
Thiabendazole—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00035	0.00166	CcSEcCtD
Thiabendazole—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00165	CcSEcCtD
Thiabendazole—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000345	0.00163	CcSEcCtD
Thiabendazole—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00163	CcSEcCtD
Thiabendazole—Nausea—Vincristine—peripheral nervous system neoplasm	0.000344	0.00163	CcSEcCtD
Thiabendazole—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000343	0.00162	CcSEcCtD
Thiabendazole—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.00161	CcSEcCtD
Thiabendazole—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000336	0.00159	CcSEcCtD
Thiabendazole—Chills—Epirubicin—peripheral nervous system neoplasm	0.000332	0.00157	CcSEcCtD
Thiabendazole—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000332	0.00157	CcSEcCtD
Thiabendazole—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.00156	CcSEcCtD
Thiabendazole—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000325	0.00154	CcSEcCtD
Thiabendazole—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.00153	CcSEcCtD
Thiabendazole—Rash—Cisplatin—peripheral nervous system neoplasm	0.000323	0.00153	CcSEcCtD
Thiabendazole—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00152	CcSEcCtD
Thiabendazole—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000321	0.00152	CcSEcCtD
Thiabendazole—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.00151	CcSEcCtD
Thiabendazole—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.0015	CcSEcCtD
Thiabendazole—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00031	0.00147	CcSEcCtD
Thiabendazole—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.00145	CcSEcCtD
Thiabendazole—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000304	0.00144	CcSEcCtD
Thiabendazole—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00144	CcSEcCtD
Thiabendazole—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000298	0.00141	CcSEcCtD
Thiabendazole—Rash—Etoposide—peripheral nervous system neoplasm	0.000296	0.0014	CcSEcCtD
Thiabendazole—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000295	0.0014	CcSEcCtD
Thiabendazole—Headache—Etoposide—peripheral nervous system neoplasm	0.000294	0.00139	CcSEcCtD
Thiabendazole—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000288	0.00136	CcSEcCtD
Thiabendazole—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.00133	CcSEcCtD
Thiabendazole—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000279	0.00132	CcSEcCtD
Thiabendazole—Nausea—Etoposide—peripheral nervous system neoplasm	0.000279	0.00132	CcSEcCtD
Thiabendazole—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.00126	CcSEcCtD
Thiabendazole—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000265	0.00125	CcSEcCtD
Thiabendazole—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000263	0.00124	CcSEcCtD
Thiabendazole—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000258	0.00122	CcSEcCtD
Thiabendazole—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00118	CcSEcCtD
Thiabendazole—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000246	0.00116	CcSEcCtD
Thiabendazole—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00116	CcSEcCtD
Thiabendazole—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.00115	CcSEcCtD
Thiabendazole—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000234	0.0011	CcSEcCtD
Thiabendazole—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.0011	CcSEcCtD
Thiabendazole—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000231	0.00109	CcSEcCtD
Thiabendazole—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00108	CcSEcCtD
Thiabendazole—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00107	CcSEcCtD
Thiabendazole—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000227	0.00107	CcSEcCtD
Thiabendazole—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00102	CcSEcCtD
Thiabendazole—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00102	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000215	0.00102	CcSEcCtD
Thiabendazole—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.00101	CcSEcCtD
Thiabendazole—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.001	CcSEcCtD
Thiabendazole—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000991	CcSEcCtD
Thiabendazole—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000982	CcSEcCtD
Thiabendazole—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000948	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.00094	CcSEcCtD
Thiabendazole—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000916	CcSEcCtD
Thiabendazole—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000909	CcSEcCtD
Thiabendazole—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000892	CcSEcCtD
Thiabendazole—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000879	CcSEcCtD
Thiabendazole—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00085	CcSEcCtD
Thiabendazole—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000847	CcSEcCtD
Thiabendazole—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000825	CcSEcCtD
Thiabendazole—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000822	CcSEcCtD
Thiabendazole—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000814	CcSEcCtD
Thiabendazole—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00079	CcSEcCtD
Thiabendazole—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000787	CcSEcCtD
Thiabendazole—Rash—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000784	CcSEcCtD
Thiabendazole—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000783	CcSEcCtD
Thiabendazole—Headache—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000779	CcSEcCtD
Thiabendazole—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00076	CcSEcCtD
Thiabendazole—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000738	CcSEcCtD
Thiabendazole—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000731	CcSEcCtD
Thiabendazole—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000725	CcSEcCtD
Thiabendazole—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000724	CcSEcCtD
Thiabendazole—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.00072	CcSEcCtD
Thiabendazole—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000683	CcSEcCtD
